As the pioneer in precision medicine, Caris was the first to provide Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) for every patient. All molecular profiling orders include next-generation sequencing of all 22,000 genes.
Caris uses the most advanced technologies for biomarker identification, allowing our medical teams to understand fully the biology of the tumor, which helps oncologists plan the best treatment strategy.
*Not available in New York state.
Place an order today for a comprehensive, personalized Caris profiling report.